During the past decade, Azienda Ospedaliera G.Salvini Ospedale di Rho conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera G.Salvini Ospedale di Rho" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Janssen-Cilag Ltd." with 3 trials sponsored, "ASST Rhodense" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Associazione Portatori Dispositivi Impiantabili Cardiaci" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera G.Salvini Ospedale di Rho" are "Crohn Disease" (4 trials), "Advanced Colorectal Cancer" (1 trials), "Cardiac Resynchronization Therapy" (1 trials), "Chronic Kidney Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera G.Salvini Ospedale di Rho" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera G.Salvini Ospedale di Rho" are "Drug" (9 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (2 trials), "2-lead CRT defibrillator system implantation" (1 trials), "Adalimumab (40 mg)" (1 trials) and "Aflibercept, 5fluorouracil, Folinic Acid andIrinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera G.Salvini Ospedale di Rho" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera G.Salvini Ospedale di Rho". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Azienda Ospedaliera G.Salvini Ospedale di Rho, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera G.Salvini Ospedale di Rho, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".